Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in the Netherlands

19 pages, Nov 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Moderate and consistently positive sales growth expected in dermatologicals

Dermatologicals in the Netherlands is expected to register a value CAGR of 3% in constant 2017 terms over the forecast period and this is set to be an improvement on the 2% of value CAGR recorded in the category at constant 2017 prices over the review period. The slow but steady sales growth expected in dermatologicals during the forecast period is a sign of the category’s maturity, although rising incidence of moderate skin problems due to the ageing of Dutch society is expected to continue supporting growth in demand for OTC dermatologicals.

General preference for Rx products set to continue limiting sales growth

The general preference for Rx dermatologicals among the Dutch population is likely to continue posing a threat to growth rates in dermatologicals. When their patients present with potentially serious skin conditions, Dutch doctors, including dermatologists, often prescribe Rx products rather than products which have OTC status and this is because Rx products are generally considered to be much more effective, while only some OTC products are reimbursable.

Diversification to be based on the proliferation of herbal/traditional dermatologicals

During the forecast period, it is expected that the leading companies in dermatologicals will take steps to diversify their product portfolios by investing in the development of more natural products. Companies present in the category can be expected to become more engaged in the further segmentation of their existing product ranges, offering products which target the needs of consumers and this is set to help them to compete with branded beauty and personal care products, with numerous leading brands expected to embrace the natural medicines trend by launching herbal/traditional alternatives to their standard OTC preparations.

COMPETITIVE LANDSCAPE

Local player Remark leads the category

Netherlands-based multinational Remark Pharma remained the leading player in dermatologicals in 2017, accounting for 15% of value sales in the category. The company continues to benefit from the strong performance of its brands Zarqa and Dr Swaab.

Local players prominent in dermatologicals

Local players remain strong in dermatologicals, mainly due to the leadership of Remark Groep BV, which offers a mixture of its own brands and brands of other manufacturers distributed under license and names such as Bio-Oil, Resdan and Zarqa are well-established in the Netherlands. The popularity of Remark Pharma’s brands is due to its multi-channel approach to distribution, which has made its products available in drugstores/parapharmacies, beauty specialist retailers, healthfood shops, supermarkets and online.

Private label struggles in dermatologicals

Private label accounted for just 8% of value sales in dermatologicals in 2017, which was half of the 16% value share held by private label in OTC overall during the year. Brand equity is much higher in dermatologicals than in other OTC categories due to the perceived importance of having healthy and attractive-looking skin, while the strong consumer loyalty towards premium products in the category is because many of these brands have been available in the Netherlands for a long time.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Netherlands market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Netherlands?
What are the major brands in Netherlands?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Moderate and consistently positive sales growth expected in dermatologicals

General preference for Rx products set to continue limiting sales growth

Diversification to be based on the proliferation of herbal/traditional dermatologicals

COMPETITIVE LANDSCAPE

Local player Remark leads the category

Local players prominent in dermatologicals

Private label struggles in dermatologicals

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Positive value growth remains a constant for consumer health

Weather conditions continue to influence sales trends in consumer health

Multinational companies remain dominant as smaller players gain ground

Changing shopping habits spur the evolution of the retail environment

Consistently positive value growth expected over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Dermatologicals in the Netherlands

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Moderate and consistently positive sales growth expected in dermatologicals

General preference for Rx products set to continue limiting sales growth

Diversification to be based on the proliferation of herbal/traditional dermatologicals

COMPETITIVE LANDSCAPE

Local player Remark leads the category

Local players prominent in dermatologicals

Private label struggles in dermatologicals

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Moderate and consistently positive sales growth expected in dermatologicals

General preference for Rx products set to continue limiting sales growth

Diversification to be based on the proliferation of herbal/traditional dermatologicals

COMPETITIVE LANDSCAPE

Local player Remark leads the category

Local players prominent in dermatologicals

Private label struggles in dermatologicals

CATEGORY DATA

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Positive value growth remains a constant for consumer health

Weather conditions continue to influence sales trends in consumer health

Multinational companies remain dominant as smaller players gain ground

Changing shopping habits spur the evolution of the retail environment

Consistently positive value growth expected over the forecast period

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports